REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2026
Back to search
Official data from USPTO
COVAWOUND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/14/2026
Trademark type
Word
Nice classes
5
Filing date
02/13/2015
Registration date
06/13/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/11/2023
Last transaction
06/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/17/2015
First use in commerce
11/19/2015
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
MCMORROW, RONALD G
Law office
M90
Current location
TMO LAW OFFICE 118
Holders and representatives
Holders
Covalon Technologies Ltd.
Representatives
Seth A. Rose LOEB & LOEB LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and surgical dressings containing antimicrobials; wound fillers in the form of hydrogels; medical and surgical dressings and bandages treated with an antimicrobial to assist in the field of wound care infection control; medical and surgical dressings and plastersnon-elastic bandages for skin woundsmaterial prepared for bandageswound dressings; dressings and bandages containing pharmaceutical preparations for wound care infection control and pain relief
Publications
History of USPTO decisions and trademark events.
38 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/11/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/11/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/13/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/06/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/05/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/27/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/27/2017
IUAF
USE AMENDMENT FILED
03/28/2017
EISU
TEAS STATEMENT OF USE RECEIVED
03/28/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2016
EX2G
SOU EXTENSION 2 GRANTED
11/07/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/07/2016
EXT2
SOU EXTENSION 2 FILED
10/19/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/19/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/26/2016
EX1G
SOU EXTENSION 1 GRANTED
04/22/2016
EXT1
SOU EXTENSION 1 FILED
04/22/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/22/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2015
PUBO
PUBLISHED FOR OPPOSITION
09/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/28/2015
ALIE
ASSIGNED TO LIE
07/27/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/13/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/21/2015
GNRT
NON-FINAL ACTION E-MAILED
05/21/2015
CNRT
NON-FINAL ACTION WRITTEN
05/21/2015
DOCK
ASSIGNED TO EXAMINER
05/21/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2015
NWAP
NEW APPLICATION ENTERED
02/17/2015
Continuous trademark protection
Get notified about every new filing that threatens COVAWOUND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.